Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-017066

Chief Accounting Officer acquired 5,967 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Weiss Amir · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-04 Exercise or conversion : show line 1 in the form +2,403 20,994.41 D
2022-03-05 Exercise or conversion : show line 2 in the form +3,564 24,558.41 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-03-04 Exercise or conversion : show line 3 in the form Restricted Share Units −2,403 2,406 D
2022-03-04 Grant or award : show line 4 in the form Restricted Share Units +42,707 42,707 D
2022-03-05 Exercise or conversion : show line 5 in the form Restricted Share Units −3,564 10,694 D
Loading xslF345X03/doc4.xml…